
Mark Kenneth Buse
Examiner (ID: 1178, Phone: (571)270-3139 , Office: P/3654 )
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654 |
| Total Applications | 844 |
| Issued Applications | 644 |
| Pending Applications | 46 |
| Abandoned Applications | 165 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20041233
[patent_doc_number] => 20250179455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 19/056045
[patent_app_country] => US
[patent_app_date] => 2025-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19056045
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/056045 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS | Feb 17, 2025 | Pending |
Array
(
[id] => 20041312
[patent_doc_number] => 20250179534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => Novel CRISPR-Cas sigma enzyme and system
[patent_app_type] => utility
[patent_app_number] => 19/011407
[patent_app_country] => US
[patent_app_date] => 2025-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19011407
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/011407 | Novel CRISPR-Cas sigma enzyme and system | Jan 5, 2025 | Pending |
Array
(
[id] => 20033534
[patent_doc_number] => 20250171756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/965935
[patent_app_country] => US
[patent_app_date] => 2024-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 178649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18965935
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/965935 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | Dec 1, 2024 | Pending |
Array
(
[id] => 19846751
[patent_doc_number] => 20250092102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => TRANSCRIPTION FACTOR NCGL0581 MUTANT AND USE THEREOF IN L-SERINE DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/957819
[patent_app_country] => US
[patent_app_date] => 2024-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/957819 | Transcription factor NCgl0581 mutant and use thereof in L-serine detection | Nov 23, 2024 | Issued |
Array
(
[id] => 19961852
[patent_doc_number] => 12331340
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-06-17
[patent_title] => Efficient synthesis and assembly method for large fragment DNA based on programmable nuclease Argonaute
[patent_app_type] => utility
[patent_app_number] => 18/915035
[patent_app_country] => US
[patent_app_date] => 2024-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 2185
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/915035 | Efficient synthesis and assembly method for large fragment DNA based on programmable nuclease Argonaute | Oct 13, 2024 | Issued |
Array
(
[id] => 20357552
[patent_doc_number] => 12473539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => RNA-guided nucleases and active fragments and variants thereof and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/781640
[patent_app_country] => US
[patent_app_date] => 2024-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 81228
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18781640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/781640 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Jul 22, 2024 | Issued |
Array
(
[id] => 20256340
[patent_doc_number] => 12428683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Method for the isolation of double-strand breaks
[patent_app_type] => utility
[patent_app_number] => 18/620640
[patent_app_country] => US
[patent_app_date] => 2024-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 22135
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 495
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/620640 | Method for the isolation of double-strand breaks | Mar 27, 2024 | Issued |
Array
(
[id] => 19449325
[patent_doc_number] => 20240309455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS
[patent_app_type] => utility
[patent_app_number] => 18/620644
[patent_app_country] => US
[patent_app_date] => 2024-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/620644 | Method for the isolation of double-strand breaks | Mar 27, 2024 | Issued |
Array
(
[id] => 19785897
[patent_doc_number] => 20250059576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES
[patent_app_type] => utility
[patent_app_number] => 18/435438
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435438
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435438 | ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES | Feb 6, 2024 | Pending |
Array
(
[id] => 19249116
[patent_doc_number] => 20240200103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/417305
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417305 | SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME | Jan 18, 2024 | Pending |
Array
(
[id] => 19464502
[patent_doc_number] => 20240318171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => CRISPR-BASED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/404826
[patent_app_country] => US
[patent_app_date] => 2024-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404826
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/404826 | CRISPR-BASED COMPOSITIONS AND METHODS OF USE | Jan 3, 2024 | Pending |
Array
(
[id] => 19233768
[patent_doc_number] => 20240190960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => ANTIGEN-BINDING MOLECULE AND COMBINATION
[patent_app_type] => utility
[patent_app_number] => 18/394091
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394091 | ANTIGEN-BINDING MOLECULE AND COMBINATION | Dec 21, 2023 | Pending |
Array
(
[id] => 19051238
[patent_doc_number] => 20240093207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/495420
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18495420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/495420 | NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF | Oct 25, 2023 | Abandoned |
Array
(
[id] => 19127521
[patent_doc_number] => 20240132874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => SYNTHETIC GENOME
[patent_app_type] => utility
[patent_app_number] => 18/493307
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493307
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493307 | Synthetic genome | Oct 23, 2023 | Issued |
Array
(
[id] => 19127521
[patent_doc_number] => 20240132874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => SYNTHETIC GENOME
[patent_app_type] => utility
[patent_app_number] => 18/493307
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493307
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493307 | Synthetic genome | Oct 23, 2023 | Issued |
Array
(
[id] => 19081892
[patent_doc_number] => 20240108693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => METHOD OF TREATING LOWER URINARY TRACT SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 18/476605
[patent_app_country] => US
[patent_app_date] => 2023-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18476605
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/476605 | METHOD OF TREATING LOWER URINARY TRACT SYMPTOMS | Sep 27, 2023 | Pending |
Array
(
[id] => 18862297
[patent_doc_number] => 20230416733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => GUIDE RNA WITH CHEMICAL MODIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/332464
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18332464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/332464 | GUIDE RNA WITH CHEMICAL MODIFICATIONS | Jun 8, 2023 | Abandoned |
Array
(
[id] => 18817798
[patent_doc_number] => 20230392138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SYNTHETIC GENOME
[patent_app_type] => utility
[patent_app_number] => 18/321475
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321475
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321475 | SYNTHETIC GENOME | May 21, 2023 | Abandoned |
Array
(
[id] => 18916853
[patent_doc_number] => 11879124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Construction method of a tight regulation system for gene expression in
[patent_app_type] => utility
[patent_app_number] => 18/315140
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4080
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 430
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/315140 | Construction method of a tight regulation system for gene expression in | May 9, 2023 | Issued |
Array
(
[id] => 19969881
[patent_doc_number] => 12338474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Compositions and methods for producing circular polyribonucleotides
[patent_app_type] => utility
[patent_app_number] => 18/168357
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 39256
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168357
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168357 | Compositions and methods for producing circular polyribonucleotides | Feb 12, 2023 | Issued |